Pamela M Price

US Patent:

7829126, Nov 9, 2010

Filed:

Oct 20, 2006

Appl. No.:

11/584704

Inventors:

Bridget Barrett-Reis - Dublin OH, US
Pamela T. Price - Granville OH, US
Amy Mackey - Columbus OH, US

Assignee:

Abbott Laboratories - Abbott Park IL

International Classification:

A61K 38/01

US Classification:

426 72, 514 2, 514 21, 426658, 426800, 426801, 424655, 424442, 424600

Abstract:

Disclosed are infant formulas and corresponding methods of using them to promote retinal health and vision development in infants. The formulas, which are free of egg phospholipids and comprise fat, protein, carbohydrate, vitamins, and minerals, including docosahexaenoic acid and, on a ready-to-feed basis, at least about 50 mcg/liter of lutein, wherein the weight ratio of lutein (mcg) to docosahexaenoic acid (mg) is from about 1:2 to about 10:1. The formulas are also believed to be especially useful in reducing the risk of retinopathy of prematurity in preterm infants.

US Patent:

8263147, Sep 11, 2012

Filed:

Mar 8, 2011

Appl. No.:

13/042802

Inventors:

Bridget Barrett-Reis - Dublin OH, US
Pamela T. Price - Granville OH, US
Amy Mackey - Columbus OH, US

Assignee:

Abbott Laboratories - Abbott Park IL

International Classification:

A61K 38/01

US Classification:

426 72, 514 2, 514 21, 426658, 426800, 426801, 424655, 424442, 424600

Abstract:

Disclosed is a method of reducing the risk or severity of retinopathy of prematurity in preterm infants. The method comprises (a) measuring skin carotenoid levels in preterm infants, preferably by Raman Spectroscopy, and then (b) administering supplemental carotenoids to those infants in need thereof, wherein the supplemental carotenoids comprise lutein, lycopene, beta-carotene, and zeaxanthin. The supplemental carotenoids may be provided by an infant formula comprising, on a ready-to-feed basis, from about 100 to about 2000 mcg/liter of total carotenoids, wherein the total carotenoids include at least about 50 mcg/liter of lutein. The formulas may further comprise docosahexaenoic acid.

US Patent:

20180077952, Mar 22, 2018

Filed:

Dec 1, 2017

Appl. No.:

15/829142

Inventors:

- Abbott Park IL, US
PAMELA T. PRICE - Granville OH, US
AMY MACKEY - Columbus OH, US

Assignee:

ABBOTT LABORATORIES - ABBOTT PARK IL

International Classification:

A23L 2/66
G01N 33/82

Abstract:

Disclosed are infant formulas and corresponding methods of using them to promote retinal health and vision development in infants. The formulas, which are free of egg phospholipids and comprise fat, protein, carbohydrate, vitamins, and minerals, including docosahexaenoic acid and, on a ready-to-feed basis, at least about 50 mcg/liter of lutein, wherein the weight ratio of lutein (mcg) to docosahexaenoic acid (mg) is from about 1:2 to about 10:1. The formulas are also believed to be especially useful in reducing the risk of retinopathy of prematurity in preterm infants.

US Patent:

20150024112, Jan 22, 2015

Filed:

Oct 10, 2014

Appl. No.:

14/512144

Inventors:

- Abbott Park IL, US
PAMELA T. PRICE - Granville OH, US
AMY MACKEY - Columbus OH, US

Assignee:

ABBOTT LABORATORIES - Abbott Park IL

International Classification:

A23L 1/29
A23L 1/30
A23L 1/305

US Classification:

426648

Abstract:

Disclosed are infant formulas and corresponding methods of using them to promote retinal health and vision development in infants. The formulas, which are free of egg phospholipids and comprise fat, protein, carbohydrate, vitamins, and minerals, including docosahexaenoic acid and, on a ready-to-feed basis, at least about 50 mcg/liter of lutein, wherein the weight ratio of lutein (mcg) to docosahexaenoic acid (mg) is from about 1:2 to about 10:1. The formulas are also believed to be especially useful in reducing the risk of retinopathy of prematurity in preterm infants.